Web Exclusive: An Excerpt from "Conquer Prostate Cancer"
June 15, 2010
Integrative Medicine: Exercise Scores Against Anxiety
June 19, 2010 – Lena Huang
Web Exclusive: Gaining Ground In Treating Metastatic Colorectal Cancer
June 15, 2010 – Kathy LaTour
Web Exclusive: Standing Up to Cancer
June 16, 2010 – Kathy LaTour
Web Exclusive: Find a Clinical Trial That's Right for You
June 16, 2010
More Therapies Needed for Childhood Cancers
June 14, 2010 – Bunmi Ishola
The Price of Parenthood
June 10, 2010 – Erik Ness
Should I Have My Child Tested?
June 09, 2010 – Charlotte Huff
Teaming Up Against Liver Cancers
June 09, 2010 – Kathy LaTour
What Is Metastatic Cancer?
June 09, 2010
Watching, Waiting, & More
June 07, 2010 – Karen Patterson
Other Leukemias
June 06, 2010 – Karen Patterson
A Friendlier Approach
June 08, 2010 – Laura Beil
Phases of Clinical Trials
June 08, 2010
Doc, Can We Talk About Clinical Trials?
June 07, 2010 – Laura Beil
Acknowledging Loss
June 06, 2010 – Michael E. Reid
How Not to Buffer
June 07, 2010 – Marc Silver
Buffer Zone
June 08, 2010 – Marc Silver
Sex and Intimacy After Cancer
June 06, 2010 – Lacey Meyer
The Genes That Bind
June 07, 2010 – Charlotte Huff
What to Expect When You're Not Expecting—Yet
June 04, 2010 – Erik Ness
ASCO Updates
June 07, 2010 – Staff Reports
Mirror Makeovers
June 07, 2010 – Kathy LaTour
A Lasting Effect on Breast Cancer Prevention
June 08, 2010 – Elizabeth Whittington
www.cancerversary.org
June 08, 2010 – Elizabeth Whittington
Q & A: Prostate Cancer Screeing Guidelines
June 08, 2010 – Len Lichtenfeld, MD
Saying Goodbye to Georgy Girl and a Designing Woman
June 08, 2010 – Bunmi Ishola
The Us TOO International Summit, Symposium & Celebration
June 08, 2010 – Bunmi Ishola
A Health Care Victory for Cancer Patients
June 07, 2010 – Bunmi Ishola
The Rules
June 01, 2010 – Leslie Starsoneck
Pipeline
June 10, 2010 – Katy Human
Beginning to End
May 30, 2010 – Valerie Bosselman
Mixing It Up
June 01, 2010 – Don Vaughan
Can an Aspirin a Day Keep Breast Cancer Away?
May 30, 2010 – Charlotte Huff
Bad Block
June 01, 2010 – Bunmi Ishola
Letters From Our Readers
June 08, 2010
Message From the Editor
June 08, 2010 – Debu Tripathy, MD
The Treatment Option You May Be Missing
June 07, 2010 – Laura Beil
Progress That's Worth the Wait
June 05, 2010 – Karen Patterson
Living on the Edge: Some Patients with Metastatic Cancer Live Long and Well
June 04, 2010 – Kathy LaTour
Web Exclusive: An Excerpt from "Conquer Prostate Cancer"
June 15, 2010
Integrative Medicine: Exercise Scores Against Anxiety
June 19, 2010 – Lena Huang
Web Exclusive: Gaining Ground In Treating Metastatic Colorectal Cancer
June 15, 2010 – Kathy LaTour
Web Exclusive: Standing Up to Cancer
June 16, 2010 – Kathy LaTour
Web Exclusive: Find a Clinical Trial That's Right for You
June 16, 2010
More Therapies Needed for Childhood Cancers
June 14, 2010 – Bunmi Ishola
The Price of Parenthood
June 10, 2010 – Erik Ness
Should I Have My Child Tested?
June 09, 2010 – Charlotte Huff
Teaming Up Against Liver Cancers
June 09, 2010 – Kathy LaTour
What Is Metastatic Cancer?
June 09, 2010
Currently Viewing
Watching, Waiting, & More
June 07, 2010 – Karen Patterson
A Friendlier Approach
June 08, 2010 – Laura Beil
Phases of Clinical Trials
June 08, 2010
Doc, Can We Talk About Clinical Trials?
June 07, 2010 – Laura Beil
Acknowledging Loss
June 06, 2010 – Michael E. Reid
How Not to Buffer
June 07, 2010 – Marc Silver
Buffer Zone
June 08, 2010 – Marc Silver
Sex and Intimacy After Cancer
June 06, 2010 – Lacey Meyer
The Genes That Bind
June 07, 2010 – Charlotte Huff
What to Expect When You're Not Expecting—Yet
June 04, 2010 – Erik Ness
ASCO Updates
June 07, 2010 – Staff Reports
Mirror Makeovers
June 07, 2010 – Kathy LaTour
A Lasting Effect on Breast Cancer Prevention
June 08, 2010 – Elizabeth Whittington
www.cancerversary.org
June 08, 2010 – Elizabeth Whittington
Q & A: Prostate Cancer Screeing Guidelines
June 08, 2010 – Len Lichtenfeld, MD
Saying Goodbye to Georgy Girl and a Designing Woman
June 08, 2010 – Bunmi Ishola
The Us TOO International Summit, Symposium & Celebration
June 08, 2010 – Bunmi Ishola
A Health Care Victory for Cancer Patients
June 07, 2010 – Bunmi Ishola
The Rules
June 01, 2010 – Leslie Starsoneck
Pipeline
June 10, 2010 – Katy Human
Beginning to End
May 30, 2010 – Valerie Bosselman
Mixing It Up
June 01, 2010 – Don Vaughan
Can an Aspirin a Day Keep Breast Cancer Away?
May 30, 2010 – Charlotte Huff
Bad Block
June 01, 2010 – Bunmi Ishola
Letters From Our Readers
June 08, 2010
Message From the Editor
June 08, 2010 – Debu Tripathy, MD
The Treatment Option You May Be Missing
June 07, 2010 – Laura Beil
Progress That's Worth the Wait
June 05, 2010 – Karen Patterson
Living on the Edge: Some Patients with Metastatic Cancer Live Long and Well
June 04, 2010 – Kathy LaTour

Watching, Waiting, & More

Helen Anbinder of Dobbs Ferry, New York, achieved a lot—and much was achieved on her behalf—in the seven years between her CLL diagnosis and treatment. 

BY Karen Patterson
PUBLISHED June 07, 2010

Helen Anbinder of Dobbs Ferry, New York, achieved a lot—and much was achieved on her behalf—in the seven years between her chronic lymphocytic leukemia diagnosis and treatment.

Anbinder, now 68, learned in 2001 that she had early-stage CLL. She consulted a specialist—Kanti R. Rai, MD, at Long Island Jewish Medical Center in New Hyde Park, New York (the Rai staging system for CLL bears his name)—and because she didn’t need treatment yet, was cared for with a “watch and wait” approach. 

But that doesn’t mean Anbinder sat still. Having sought information about her disease from the Leukemia & Lymphoma Society (LLS)—and having heard of the remarkable success of the drug Gleevec (imatinib) for another type of leukemia, chronic myeloid leukemia—she had a ready answer months later when her brother- and sister-in-law, Stephen and Madeline Anbinder of New York City, wanted to make a charitable gift of more than $200,000 in her honor. 

“Without hesitation I said I wanted it to go for CLL research,” says Helen, a retired administrator of a local continuing education program. “News had come out about Gleevec, but I could see nothing of that nature in the pipeline for CLL.” 

She met with the LLS and decided to earmark the money for research by The Ohio State University’s John Byrd, MD, and colleagues, who were testing a new CLL treatment protocol combining Fludara (fludarabine) and Rituxan (rituximab) (FR).

In 2004, Helen Anbinder formed a family-and-friends team for the society’s Light The Night Walk, raising $6,100. By the time her CLL needed treatment in 2008, Anbinder’s team had racked up more than $67,000 in the annual events. She also began volunteering in the LLS’s Westchester/Hudson Valley chapter office—she now serves on its board—and in 2005 appeared in a national video highlighting the society’s work.

As it turns out, the treatment Rai finally recommended for her was the very protocol Byrd was testing. Three cycles of FR and Anbinder was in remission. “It actually worked too well,” she says—her white cell count plummeted after the first round and she was hospitalized for a respiratory infection. Subsequent cycles were shortened from five days to four.

Like Energizer bunnies, the Anbinder clan has kept going. Their fund-raising team’s total now exceeds $111,000. Anbinder helps with LLS donor development and supports newly diagnosed patients through the society’s First Connections program. Her younger son, Jeff, bicycles to raise money for LLS. And her in-laws continue to contribute annually to CLL research.

Although Anbinder reports her white cell count is climbing again, she continues her many travels abroad with her husband, Paul. At some point she expects to need more treatment—very possibly, she says, that same treatment that worked so well for her before.

Be the first to discuss this article on CURE's forum. >>
Talk about this article with other patients, caregivers, and advocates in the General Discussions CURE discussion group.

Related Articles

1
×

Sign In

Not a member? Sign up now!
×

Sign Up

Are you a member? Please Log In